Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVERS.L Regulatory News (VERS)

  • There is currently no data for VERS

Depository Interest Programme

28 Aug 2015 09:34

RNS Number : 4311X
Verseon Corporation
28 August 2015
 



Verseon Corporation

("Verseon" or the "Company")

 

Depository Interest Programme

 

Verseon Corporation (AIM: VSN) announces that it has introduced a Depository Interest programme ("DI Programme") in respect of its common shares ("Common Shares") with the Company's registrar, Computershare Investor Services PLC ("Computershare"), to enable the Common Shares to be settled electronically via CREST.

 

It is expected that the DI Programme will be effective from 1 September 2015. The Company's existing ISIN (USU9221J1098) and ticker (VSN) will remain the same and, from 1 September 2015, will represent the depository interests ("Verseon Depository Interests"). The introduction of the DI Programme will ensure that Verseon will be in compliance with the AIM Rules and EU regulations which require securities traded on AIM to be capable of electronic settlement with effect from 1 September 2015. The benefit of the DI Programme is that the Verseon Depository Interests can be held and transferred through CREST, which should shorten the settlement process significantly. This will potentially widen the pool of investors that can hold the securities by making them available to investors who are unable to hold securities which are not eligible for electronic settlement.

 

Shareholders should note that from 1 September 2015, holdings of certificated Common Shares will be eligible for dematerialisation into Verseon Depository Interests which shall be capable of electronic settlement in CREST. Shareholders are encouraged to contact their broker or Computershare directly on +44 (0)370 707 4040 for further details on the DI Programme and how to dematerialise their holding of Common Shares.

 

As described in more detail in the Company's admission document published on 1 May 2015, which is available on the Company's website, the Company's securities are subject to certain restrictions on transfers under Regulation S of the United States Securities Act of 1933, as amended. This restriction, which appears as a legend on the certificated Common Shares, shall continue to apply to the Verseon Depository Interests. The distribution compliance period in respect of the Common Shares issued pursuant to the admission document expires on 7 May 2016 and the Company will make a further announcement closer to that date with details of an unrestricted depository interest line of security which would have a different ticker and ISIN, into which eligible Verseon Depository Interests or Common Shares may be transferred or placed.

 

Any enquiries should be directed to Computershare on +44 (0)370 707 4040.

 

 

Contact details:

 

Computershare Investor Services (Jersey)

+44 (0)370 707 4040

 

Verseon Corporation

+1 (510) 225 9000

Adityo Prakash, Chief Executive Officer

 

Cenkos Securities (NOMAD and Broker)

+44 (0) 20 7397 8900

Christopher Golden / Mark Connelly

 

FTI Consulting (PR Advisers)

+44 (0) 20 3727 1000

Simon Conway / Robert Winder / Matthew Moss

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUPWRUPAURR
Date   Source Headline
27th Oct 20168:41 amRNSAdditional Listing & Total Voting Rights
21st Sep 20167:00 amRNSDirector/PDMR Shareholding
12th Sep 20167:00 amRNSAdditional Listing & Total Voting Rights
8th Sep 20167:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
5th Sep 20167:00 amRNSInterim Results
9th Aug 201611:40 amRNSAdditional Listing & Total Voting Rights
22nd Jun 20167:00 amRNSAdditional Listing & Total Voting Rights
6th Jun 20167:00 amRNSVerseon to Present Latest Anticoagulant Results
27th Apr 20167:00 amRNSAdditional Listing & Total Voting Rights
21st Apr 20167:00 amRNSResult of AGM
7th Apr 20167:00 amRNSNotice of AGM
6th Apr 20167:00 amRNSTR-1: Notification of Major Interest in Shares
4th Apr 20167:00 amRNSVerseon to present additional results at BioEurope
21st Mar 20167:00 amRNSHoldings in Company
17th Mar 20167:00 amRNSAdditional Listing & Total Voting Rights
7th Mar 20167:00 amRNSFinal Results
1st Mar 20167:00 amRNSAdditional Listing & Total Voting Rights
29th Feb 20167:00 amRNSVerseon presents low bleeding risk anticoagulants
10th Feb 20167:00 amRNSVerseon to present new preclinical results at ICHB
4th Feb 20167:00 amRNSAdditional Listing & Total Voting Rights
12th Jan 20167:00 amRNSVerseon to Present Data
29th Dec 201510:15 amRNSAdditional Listing & Total Voting Rights
29th Oct 20157:00 amRNSAdditional Listing & Total Voting Rights
25th Sep 20157:00 amRNSAdditional Listing & Total Voting Rights
17th Sep 20157:00 amRNSTR-1: Notification of Major Interest in Shares
15th Sep 20157:00 amRNSTR-1: Notification of Major Interest in Shares
7th Sep 20157:00 amRNSInterim Results
28th Aug 20159:34 amRNSDepository Interest Programme
20th Aug 20158:55 amRNSVerseon Acquires R&D Facility
19th Aug 20159:09 amRNSAdditional Listing & Total Voting Rights
22nd Jul 20158:39 amRNSAdditional Listing & Total Voting Rights
29th Jun 20158:58 amRNSAnnual Report Announcement
25th Jun 20159:57 amRNSHolding(s) in Company
17th Jun 20157:00 amRNSAdditional Listing & Total Voting Rights
7th May 20158:12 amRNSAIM Admission - First day of dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.